Circulating Tumor DNA-Guided Recurrence Risk Assessment in Esophageal and Gastric Cancer: Assay Holds the Key

JCO Precis Oncol. 2023 Mar:7:e2200710. doi: 10.1200/PO.22.00710.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Circulating Tumor DNA* / genetics
  • Esophageal Neoplasms* / diagnosis
  • Esophageal Neoplasms* / genetics
  • Esophageal Neoplasms* / pathology
  • Humans
  • Risk Assessment
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / pathology

Substances

  • Circulating Tumor DNA